|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product revenues, net | |||||
| Product royalty revenues | |||||
| Milestone and contract revenues | |||||
| Total revenues | |||||
| Costs, expenses and other: | |||||
| Cost of product revenues (including definite-lived intangible amortization) | |||||
| Contract dispute settlement | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Asset impairment | |||||
| (Gain) loss on change in fair value of acquisition-related contingent consideration | |||||
| (Profit) and loss sharing under collaboration agreements | |||||
| Total costs, expenses and other | |||||
| Income from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain on equity investments | |||||
| Other, net | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used in computing net income per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...